1. Introduction {#sec1-jcm-08-00670}
===============

In recent years, several studies have highlighted some specific risk factors for revision surgery in total hip and knee arthroplasties (THA and TKA), including patient factors like sex, age or comorbidity; intervention factors like type of prosthesis or type of fixation; and hospital factors like the circumstances of admission or the number of procedures performed each year \[[@B1-jcm-08-00670],[@B2-jcm-08-00670]\]. The relationship between some of these variables and the risk of revision is clear and consistently found in gender, age and the year the primary procedure was performed \[[@B3-jcm-08-00670],[@B4-jcm-08-00670],[@B5-jcm-08-00670]\]. Nevertheless, the relationship with some hospital and healthcare related variables remains unclear. Due to the possible relationship to the THA and TKA revision, the number of procedures performed per year by the hospital or hospital volume by year has been pointed out \[[@B6-jcm-08-00670],[@B7-jcm-08-00670]\].

Previous studies have shown varying results when examining the relationship between the hospital volume by year and the risk of revision but after focusing on these results, the evidence found is inconsistent \[[@B6-jcm-08-00670],[@B7-jcm-08-00670],[@B8-jcm-08-00670],[@B9-jcm-08-00670],[@B10-jcm-08-00670],[@B11-jcm-08-00670],[@B12-jcm-08-00670],[@B13-jcm-08-00670],[@B14-jcm-08-00670],[@B15-jcm-08-00670]\]. While some of them have not found any association between the hospital volume and the risk of revision \[[@B9-jcm-08-00670],[@B10-jcm-08-00670],[@B11-jcm-08-00670]\], other studies have suggested a possible higher risk of revision for primary prostheses in lower volume hospitals over higher volume, both at medium- and long-term follow-up \[[@B6-jcm-08-00670],[@B7-jcm-08-00670],[@B12-jcm-08-00670],[@B13-jcm-08-00670],[@B14-jcm-08-00670]\]. Differences in the results previously found might be related to the context of the study. As mentioned in prior research, an explanation for the difference in results could be the possible case-mix between volume groups \[[@B8-jcm-08-00670],[@B16-jcm-08-00670]\], meaning the characteristics of patients undergoing an arthroplasty could vary between hospital volume groups. Therefore, it could be advantageous to take this possibility into account to obtain a more accurate representation of how the volume by year could be related to the incidence of revision in THA and TKA.

Regarding the methodology used in the aforementioned studies, most of them were performed without matching cohorts from different volume groups. Due to differences in the characteristics of patients between volume groups, the conclusions drawn from these cohorts might not be comparable. As such, using propensity scores in the last few years to match different populations has become popular \[[@B16-jcm-08-00670],[@B17-jcm-08-00670]\]. These scores might allow comparable cohorts to be acquired and could reduce the bias when comparing the results between them.

Therefore, the aims of this study were: (1) To obtain comparable cohorts in higher and lower volume hospitals and (2) to assess the association between the THA and TKA volume by year and the incidence of revision at one, five and 10 years in Catalonia.

2. Experimental Section {#sec2-jcm-08-00670}
=======================

2.1. Design and Study Population {#sec2dot1-jcm-08-00670}
--------------------------------

A prospective observational design based on data from the Catalan Arthroplasty Register (RACat) and the Minimum Basic Dataset at hospital discharge (MBD-HD) was drawn up. The RACat is a population-based arthroplasty register that has collected data about hip and knee arthroplasties performed in Catalonia since 2005. The RACat includes 53 out of 61 public hospitals in Catalonia with approximately 830 surgeons performing hip and knee arthroplasties. The completeness of the RACat is about 90% for primary arthroplasties and about 70% for revision procedures \[[@B18-jcm-08-00670]\]. The MBD-HD is a mandatory, payment-related health database that includes information about the patient and the surgical procedure, like diagnosis (including ICD-9-CM codes) and the reason for intervention and revision. The MBD-HD dataset is merged with the RACat dataset using a common identification number as well as other variables like surgery date and hospital admission and discharge dates. Furthermore, and given its mandatory nature, the MBD-HD is used as a standard to calculate the completeness of the RACat.

The study population included all patients undergoing a THA (conventional) or a TKA (including cruciate retaining and posterior stabilized) caused by osteoarthritis and recorded in the Catalan Arthroplasty Register (RACat) between January 2005 and December 2016. In total, the present study includes 18,283 patients undergoing THA and 45,553 TKA. After matching, a total of 13,772 THA from 46 hospitals ([Figure 1](#jcm-08-00670-f001){ref-type="fig"}) and 36,316 TKA from 49 hospitals ([Figure 2](#jcm-08-00670-f002){ref-type="fig"}) remained in the study.

2.2. Study Variables {#sec2dot2-jcm-08-00670}
--------------------

The main outcome considered in this study was the revision of the primary arthroplasty. A revision procedure is defined within the RACat, both for THA and TKA, as any procedure involving removal, exchange or addition of any implant component.

The volume of THA and TKA procedures performed by year in the hospitals participating in the RACat during the study period was taken as the main exploratory factor. The hospital volume was considered as a dichotomous variable (higher/lower), based both on the cut-off values fixed on previous research on this topic \[[@B6-jcm-08-00670],[@B7-jcm-08-00670],[@B12-jcm-08-00670]\], and on the number of THA and TKA procedures performed by year in the Catalan hospitals. For THA, hospitals performing fewer than 50 procedures per year were considered low-volume hospitals. For TKA, hospitals performing fewer than 125 procedures per year were considered low-volume hospitals. A hospital could provide cases to either the high- or low-volume group, depending on the number of procedures performed in a specific year.

The following confounders were considered: Sex (men and women), age (\<65, 65--74, 75--84, and ≥85 years old), comorbidity on the Elixhauser index (no comorbidity, one or two comorbidities, and three or more comorbidities), year of intervention (2005/2007, 2008/2010, 2011/2013, and 2014/2016) and type of fixation (cemented, cementless, hybrid, reverse hybrid, and not specified).

2.3. Data Analysis {#sec2dot3-jcm-08-00670}
------------------

Descriptive analyses of THA and TKA populations pre- and post-matching were performed, and differences were tested using Chi-Square tests. To select comparable populations, a propensity score matching method 1:1 was used, considering hospital volume as the exposure and sex, age, comorbidity, year of intervention and type of fixation as confounders. The incidence of revision at one, five and 10 years was obtained using the Kaplan--Meier method taking the competing risk of death into account. The incidence of revision was estimated by calculating t S(t−1) × h'(t), where S(t−1) is the Kaplan--Meier estimate of the overall survival function and h'(t) is the cause-specific hazard at time t. In addition, to evaluate differences in risk of revision, competing risks models were fitted, considering death as the competing event and hospital volume as the main exposure. From these models, subhazard ratios (SHRs) for revision and their 95% confidence intervals (95% CI) were obtained. All models and all analyses were stratified by the joint operated on. The significance level was fixed at α = 0.05 and all analyses were performed using Stata version 14 \[[@B19-jcm-08-00670]\].

3. Results {#sec3-jcm-08-00670}
==========

In total, 11,132 patients undergoing THA in 28 higher-volume hospitals and 7151 from 46 lower-volume hospitals were included ([Table 1](#jcm-08-00670-t001){ref-type="table"}). In terms of TKA, a total of 24,683 patients from 30 higher-volume hospitals and 20,870 from 49 lower-volume hospitals were included ([Table 2](#jcm-08-00670-t002){ref-type="table"}). After matching, 6886 patients undergoing THA and 18,158 undergoing TKA for each volume group remained in the study. Prior to matching, both for THA and TKA, statistically significant differences (*p* \< 0.05) in all confounders (sex, age, comorbidity on the Elixhauser index, year of intervention and type of fixation) between higher- and lower-volume groups were observed. After matching, none of these differences remained significant.

In THA, the most frequent causes of revision were aseptic loosening (*n* = 70, 33.7%), infection (*n* = 48, 23.1%), dislocation (*n* = 33, 15.9%) and mechanical complications (*n* = 30, 14.4%) for the higher-volume group, and aseptic loosening (*n* = 48, 28.4%), dislocation (*n* = 46, 27.2%), mechanical complications (*n* = 25, 14.8%) and infection (*n* = 23, 13.6%) for the lower-volume group. In addition, [Figure 3](#jcm-08-00670-f003){ref-type="fig"} shows the cumulative incidence of revision in THA by the volume group and the magnitude of the differences in the risk of revision between volume groups in THA. The cumulative incidence of revision was 1.31% (95% CI: 1.06--1.61), 2.85% (95% CI: 2.45--3.31) and 4.61% (95% CI: 3.88--5.43) at one, five and 10 years' follow-up in patients operated on in the higher-volume group hospitals and 0.97% (95% CI: 0.76--1.23), 2.32% (95% CI: 1.95--2.74) and 3.63% (95% CI: 3.06--4.27), respectively in patients from lower-volume hospitals. Taking the differences in the risk of revision into account ([Table 3](#jcm-08-00670-t003){ref-type="table"}), a higher risk of revision was observed in higher-volume hospitals than in lower-volume hospitals (SHR: 1.25, 95% CI: 1.02--1.53).

Regarding TKA, the most frequent causes of revision were mechanical complications (*n* = 254, 35.7%), aseptic loosening (*n* = 233, 32.7%), infection (*n* = 152, 21.4%) and dislocation (*n* =16, 2.3%) for the higher-volume group, and aseptic loosening (*n* = 252, 44.8%), mechanical complications (*n* = 137, 24.4%), infection (*n* = 88, 15.7%) and dislocation (*n* = 14, 2.5%) for the lower-volume group. Additionally, the cumulative incidence of revision ([Figure 4](#jcm-08-00670-f004){ref-type="fig"}) was 1.15% (95% CI: 1.00--1.32) at one year, 4.17% (95% CI: 3.85--4.50) at five years' and 5.8% (95% CI: 5.33--6.39) at 10 years' follow-up for the higher-volume group, and 0.64% (95% CI: 0.53--0.77), 3.24% (95% CI: 2.96--3.53) and 4.7% (95% CI: 4.21--5.13) for the lower-volume group. After examining the differences in risk of revision in TKA ([Table 4](#jcm-08-00670-t004){ref-type="table"}), a significant higher risk of revision was observed when the volume by year was higher than when it was lower (SHR: 1.29, 95% CI: 1.16--1.44).

4. Discussion {#sec4-jcm-08-00670}
=============

Our study overcomes a few methodological limitations of previous research and shows that, nowadays in Catalonia, the volume of THA and TKA procedures performed in a hospital per year could be related to the incidence of revision. Contrary to previous research focused on other contexts carried out using unmatched cohorts \[[@B6-jcm-08-00670],[@B7-jcm-08-00670],[@B12-jcm-08-00670],[@B13-jcm-08-00670],[@B14-jcm-08-00670]\], higher-volume hospitals could have a higher risk of revision in their primary prostheses than lower-volume centers in Catalonia.

Some studies that have analyzed the relationship between the volume of THA and TKA procedures by year and the risk of revision, have not found any relationship between them \[[@B9-jcm-08-00670],[@B11-jcm-08-00670]\]. Nevertheless, recent research carried out with large samples at the national level \[[@B6-jcm-08-00670],[@B7-jcm-08-00670],[@B12-jcm-08-00670]\], both for THA and TKA, have reported results that suggest a higher risk of revision in patients operated on in lower-volume hospitals than in higher-volume hospitals. In this sense, both the study performed with more than 40,000 THA, based on the Nordic Arthroplasty Register Association database \[[@B7-jcm-08-00670]\], and a study with more than 25,000 TKA from Norway \[[@B12-jcm-08-00670]\], suggest that lower-volume hospitals might have an increased long-term risk of revision. Our results were contradictory to this hypothesis, showing an opposite association between the annual hospital THA volume and long-term risk of revision.

As far as we know, only one previous study has found a slightly higher risk of revision in higher-volume hospitals \[[@B8-jcm-08-00670]\]. While the authors of that study hypothesized that their results could be caused by a possible case-mix between volume groups, our study has similar results after overcoming this issue by using propensity-score matched cohorts \[[@B16-jcm-08-00670],[@B17-jcm-08-00670]\]. These results, at least in Catalonia, could be partially explained by factors related to the healthcare organization. Higher-volume hospitals are usually centers that have residents, students in training and more healthcare personnel than lower-volume hospitals. That said, in higher-volume hospitals it is usually much more difficult to deal with environmental factors that might be a potential cause of infection, as was suggested by our results about the causes of revision by the volume group. Additionally, patients from higher-volume hospitals might have been operated on by a surgical trainee, a factor that could be related to higher revision rates due to the learning curve \[[@B8-jcm-08-00670],[@B20-jcm-08-00670],[@B21-jcm-08-00670]\]. In the lower-volume hospitals in Catalonia, usually only one surgeon performs each type of arthroplasty. Due to this, despite the lower volume by hospital, the volume by surgeon could be high, a factor that has been related to lower revision rates \[[@B13-jcm-08-00670],[@B14-jcm-08-00670],[@B22-jcm-08-00670]\]. Further research using matched cohorts from different healthcare contexts, e.g., using data from different countries' or cultures' registers, using different cut-off values to divide between higher- and lower-volume groups, and accounting for surgeon and hospital-environment related variables, could help improve our understanding of how volume by year is related to the incidence of revision. Depending on the context, this knowledge might help define specific healthcare organizational measures in an attempt to reduce the burden of revision in THA and TKA.

There are some limitations in this study that need to be discussed. First, the completeness of primary THA in the RACat is not 100%, especially during the first years of its implementation, and it is possible that not all primary and revision procedures were reported in those years. However, no disparity in collecting revisions between high- and low-volume hospitals was observed \[[@B18-jcm-08-00670]\]. Furthermore, the number of prostheses with a follow-up of 10 years is very low but this trend may change in the future. Regarding the specific prosthesis model or brand used in the different hospitals, due to limitations in the robustness and validity of the estimations related to differences between hospitals in their use and to the small sample size of some of these models, this potential confounder was not included. Future research with larger sample sizes accounting for this factor could be valuable in obtaining a more precise representation of how the volume by year affects the outcomes in THA and TKA. Another limitation is the fixed cut-off point to differentiate higher- and lower-volume groups. This variable could be taken as a continuous variable or changed to include a larger number of categories based on different cut-off values. Despite this, these cut-off points were based on those used in previous research with similar aims \[[@B6-jcm-08-00670],[@B7-jcm-08-00670],[@B12-jcm-08-00670]\] and dichotomized due to the low number of patients in some categories after we tested it as a five- and three-category variable. Furthermore, the dichotomization allows us to match the higher- and lower-volume cohorts, making them comparable within the confounders included. In addition, the crossover between hospital volume groups was not taken into account. Nevertheless, as observed in hospitals participating in the RACat \[[@B18-jcm-08-00670]\], this change of the volume group was, in most cases, an increasing or decreasing trend of hospital activity. Finally, due to the data captured in the RACat, it is important to indicate that we studied the hospital volume and not surgeon volume, which may influence our estimates. Furthermore, there is a lack of surgeon-related data and the number of surgeons by hospital is unknown, which are factors that could have a mediating effect between the volume and the risk of revision. In addition, we only considered primary procedure revisions, not other outcomes like patient reported outcome measures (PROMs). Nevertheless, it is important to mention that these limitations could be overcome in the upcoming years because the RACat has been mandatory since 2017, and is beginning to capture surgeon data as well as data on other variables and outcomes like PROMs.

In conclusion, our study shows that hospitals performing a higher volume of arthroplasties in Catalonia have an increased risk of revision due to all causes, compared to low-volume hospitals. Further research taking other variables into account and involving registers from different countries could be valuable to better understand this relationship and define specific context-dependent measures to try to reduce the incidence of revision in both THA and TKA.
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jcm-08-00670-t001_Table 1

###### 

Characteristics of the total hip arthroplasty study population prior to and after matching. RACat 2005--2016.

                                 Pre-Matching           Post-Matching                                                     
  ------------------------------ -------------- ------- --------------- ------- --------- ------- ------- ------- ------- -------
  **Sex**                                                                       0.044                                     0.495
  Men                            5,439          48.86   3,603           50.38             3,426   49.75   3,466   50.33   
  Women                          5,693          51.14   3,548           49.62             3,460   50.25   3,420   49.67   
  **Age**                                                                       0.015                                     0.416
  \<65                           3,317          29.80   2,047           28.63             2,014   29.25   2,001   29.06   
  65--74                         3,822          34.33   2,464           34.46             2,331   33.85   2,372   34.45   
  75--84                         3,562          32.00   2,408           33.67             2,287   33.21   2,293   33.30   
  ≥85                            431            3.87    232             3.24              254     3.69    220     3.19    
  **Comorbidity (Elixhauser)**                                                  0.020                                     0.821
  no comorbidity                 4,351          39.09   2,65            37.06             2,565   37.25   2,583   37.51   
  1--2 comorbidities             5,8            52.10   3,866           54.06             3,723   54.07   3,690   53.59   
  3 or more comorbidities        981            8.81    635             8.88              598     8.68    613     8.90    
  **Year of intervention**                                                                                                0.993
  2005/2007                      982            8.82    1,116           15.61             875     12.71   868     12.61   
  2008/2010                      2,999          26.94   2,038           28.50             2,025   29.41   2,035   29.55   
  2011/2013                      3,871          34.77   2,253           31.51             2,258   32.79   2,248   32.65   
  2014/2016                      3,280          29.46   1,744           24.39             1,728   25.09   1,735   25.20   
  **Type of fixation**                                                          \<0.001                                   0.700
  Cemented                       906            8.14    719             10.05             666     9.67    636     9.24    
  Cementless                     7,561          67.92   4,93            68.94             4,762   69.15   4,786   69.50   
  Hybrid                         2,512          22.57   1,397           19.54             1,388   20.16   1,384   20.10   
  Reverse hybrid                 106            0.95    93              1.30              70      1.02    80      1.16    
  Not specified                  47             0.42    12              0.17              .       .       .       .       
  **Number of hospitals**        28             46                      28      46                                        
  **Median follow-up (IQR)**     4.6 (4.5)              4.8 (4.7)                                                         

Higher volume: Fifty or more procedures per year in total hip arthroplasty and 125 or more procedures per year in total knee arthroplasty; n: number of patients; %: Percentage of patients; *p*: *p* value based on Chi-Square tests; comorbidity (Elixhauser): Number of comorbidities from Elixhauser index.

jcm-08-00670-t002_Table 2

###### 

Characteristics of the total knee arthroplasty study population prior to and after matching. RACat 2005--2016.

                                 Pre-Matching           Post-Matching                                                       
  ------------------------------ -------------- ------- --------------- ------- --------- -------- ------- -------- ------- -------
  **Sex**                                                                       \<0.001                                     0.709
  Men                            6,971          28.24   6,220           29.80             5,140    28.31   5,108    28.13   
  Women                          17,712         71.76   14,65           70.20             13,018   71.69   13,050   71.87   
  **Age**                                                                       \<0.001                                     0.950
  \<65                           4,02           16.29   3,608           17.29             3,117    17.17   3,157    17.39   
  65--74                         10,747         43.54   9,151           43.85             8,015    44.14   7,976    43.93   
  75--84                         9,363          37.93   7,767           37.22             6,729    37.06   6,729    37.06   
  ≥85                            553            2.24    344             1.65              297      1.64    296      1.63    
  **Comorbidity (Elixhauser)**                                                  \<0.001                                     0.886
  no comorbidity                 6,633          26.87   6,533           31.30             5,154    28.38   5,115    28.17   
  1--2 comorbidities             14,871         60.25   12,01           57.55             10,860   59.81   10,904   60.05   
  3 or more comorbidities        3,179          12.88   2,327           11.15             2,144    11.81   2,139    11.78   
  **Year of intervention**                                                      \<0.001                                     0.756
  2005/2007                      2,994          12.13   3,287           15.75             2,328    12.82   2,388    13.15   
  2008/2010                      6,846          27.74   6,097           29.21             5,493    30.25   5,428    29.89   
  2011/2013                      7,136          28.91   6,36            30.47             5,711    31.45   5,700    31.39   
  2014/2016                      7,707          31.22   5,126           24.56             4,626    25.48   4,642    25.56   
  **Type of fixation**                                                          \<0.001                                     0.292
  Cemented                       18,901         76.57   16,769          80.35             15,619   86.02   15,616   86.00   
  Cementless                     205            0.83    152             0.73              91       0.50    148      0.82    
  Hybrid                         3,491          14.14   2,545           12.19             2,421    13.33   2,367    13.04   
  Reverse hybrid                 184            0.75    30              0.14              27       0.15    27       0.15    
  Not specified                  1,902          7.71    1,374           6.58              .        .       .                
  **Number of hospitals**        30             49                      30      49                                          
  **Median follow-up (IQR)**     4.8 (5.0)              4.9 (4.7)                                                           

Higher volume: Fifty or more procedures per year in total hip arthroplasty and 125 or more procedures per year in total knee arthroplasty; n: Number of patients; %: Percentage of patients; p: *p* value based on Chi-Square tests; comorbidity (Elixhauser): Number of comorbidities from Elixhauser index.
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###### 

Cumulative revision and differences by hospital volume of procedures by year in total hip arthroplasty (THA). RACat 2005--2016.

  Time (in Years)     At Risk   Revisions   Cum. Failure (95% CI)   SHR (95% CI)
  ------------------- --------- ----------- ----------------------- -------------------
  **Lower volume**                                                  1.00
  1                   6,258     66          0.97 (0.76--1.23)       
  5                   3,353     70          2.32 (1.95--2.74)       
  10                  352       32          3.63 (3.06--4.27)       
  **Higher volume**                                                 1.25 (1.02--1.53)
  1                   6,239     89          1.31 (1.06--1.61)       
  5                   3,214     82          2.85 (2.45--3.31)       
  10                  389       36          4.61 (3.88--5.43)       

At risk: Number of primary procedures at the beginning of the period. Revisions: Number of revision procedures during the period; cum. failure: Cumulative failure; (95% CI): 95% confidence interval. SHR: Subhazard ratio for the hospital volume (Lower volume as reference category) adjusted for sex, age, comorbidity (from Elixhauser index), year of intervention and type of fixation.

jcm-08-00670-t004_Table 4

###### 

Cumulative revision and differences by hospital volume of procedures by year in total knee arthroplasty (TKA). RACat 2005--2016.

  Time (in Years)     At Risk   Revisions   Cum. Failure (95% CI)   SHR (95% CI)
  ------------------- --------- ----------- ----------------------- -------------------
  **Lower volume**                                                  1.00
  1                   16,594    112         0.64 (0.53--0.77)       
  5                   9,064     366         3.24 (2.96--3.53)       
  10                  1,217     80          4.66 (4.21--5.13)       
  **Higher volume**                                                 1.29 (1.16--1.44)
  1                   16,293    202         1.15 (1.00--1.32)       
  5                   8,673     422         4.17 (3.85--4.50)       
  10                  744       89          5.84 (5.33--6.39)       

At risk: Number of primary procedures at the beginning of the period. Revisions: Number of revision procedures during the period; cum. failure: Cumulative failure; (95% CI): 95% confidence interval. SHR: Subhazard ratio for the hospital volume (Lower volume as reference category) adjusted for sex, age, comorbidity (from Elixhauser index), year of intervention and type of fixation.
